Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaori Furukawa

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Bioorganic & Medicinal Chemistry|March 9, 2020
siRNA delivery using amphipathic cell-penetrating peptides into human hepatoma cellsKaori Furukawa, Masakazu Tanaka, Makoto Oba
Scientific Reports|January 28, 2016
A Cell-Penetrating Peptide with a Guanidinylethyl Amine Structure Directed to Gene DeliveryMakoto Oba, Takuma Kato, Kaori Furukawa, et al.
Clinical Immunology (Orlando, Fla.)|April 23, 2021
Systemic lupus erythematosus overlapping dermatomyositis owing to a heterozygous TREX1 Asp130Asn missense mutationYushiro Endo, Tomohiro Koga, Hiroki Otaki, et al.
Clinical Immunology (Orlando, Fla.)|January 12, 2023
CaMK4 expression on effector memory T cells is associated with organ damage in systemic lupus erythematosus: A case reportTomohiro Koga, Remi Sumiyoshi, Sosuke Tsuji, et al.
Immunological Medicine|October 23, 2024
Investigating the impact of tocilizumab on serum cytokines concentrations in Japanese FMF patients: a sub-analysis of the NUH01FMF studyTomohiro Koga, Shuntaro Sato, Kaori Furukawa, et al.
Modern Rheumatology|July 24, 2020
Genetic and clinical characteristics associated with efficacy and retention rates of colchicine in Japanese patients with familial Mediterranean fever: A single-center observational studyKazusato Hara, Tomohiro Koga, Yushiro Endo, et al.
Clinical and Experimental Rheumatology|September 10, 2019
Late-onset protracted febrile myalgia syndrome successfully treated with colchicine owing to heterozygous MEFV exon 2 variantsYushiro Endo, Tomohiro Koga, Kaori Furukawa, et al.
Clinical and Experimental Immunology|June 7, 2021
Mediterranean fever gene variants modify clinical phenotypes of idiopathic multi-centric Castleman diseaseYushiro Endo, Tomohiro Koga, Yoshihumi Ubara, et al.
Clinical Immunology (Orlando, Fla.)|August 1, 2020
Successful canakinumab treatment for activated innate response in idiopathic Castleman's disease with multiple heterozygous MEFV exon 2 variantsYushiro Endo, Tomohiro Koga, Masataka Umeda, et al.
Clinical Immunology (Orlando, Fla.)|March 8, 2020
A case of γδ T-cell large granular lymphocytic leukemia due to a chronic active Epstein-Barr virus infection in systemic lupus erythematosusMomoko Okamoto, Kunihiro Ichinose, Shinya Sato, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry|March 9, 2020
siRNA delivery using amphipathic cell-penetrating peptides into human hepatoma cellsKaori Furukawa, Masakazu Tanaka, Makoto Oba
Scientific Reports|January 28, 2016
A Cell-Penetrating Peptide with a Guanidinylethyl Amine Structure Directed to Gene DeliveryMakoto Oba, Takuma Kato, Kaori Furukawa, et al.
Clinical Immunology (Orlando, Fla.)|April 23, 2021
Systemic lupus erythematosus overlapping dermatomyositis owing to a heterozygous TREX1 Asp130Asn missense mutationYushiro Endo, Tomohiro Koga, Hiroki Otaki, et al.
Clinical Immunology (Orlando, Fla.)|January 12, 2023
CaMK4 expression on effector memory T cells is associated with organ damage in systemic lupus erythematosus: A case reportTomohiro Koga, Remi Sumiyoshi, Sosuke Tsuji, et al.
Immunological Medicine|October 23, 2024
Investigating the impact of tocilizumab on serum cytokines concentrations in Japanese FMF patients: a sub-analysis of the NUH01FMF studyTomohiro Koga, Shuntaro Sato, Kaori Furukawa, et al.
Modern Rheumatology|July 24, 2020
Genetic and clinical characteristics associated with efficacy and retention rates of colchicine in Japanese patients with familial Mediterranean fever: A single-center observational studyKazusato Hara, Tomohiro Koga, Yushiro Endo, et al.
Clinical and Experimental Rheumatology|September 10, 2019
Late-onset protracted febrile myalgia syndrome successfully treated with colchicine owing to heterozygous MEFV exon 2 variantsYushiro Endo, Tomohiro Koga, Kaori Furukawa, et al.
Clinical and Experimental Immunology|June 7, 2021
Mediterranean fever gene variants modify clinical phenotypes of idiopathic multi-centric Castleman diseaseYushiro Endo, Tomohiro Koga, Yoshihumi Ubara, et al.
Clinical Immunology (Orlando, Fla.)|August 1, 2020
Successful canakinumab treatment for activated innate response in idiopathic Castleman's disease with multiple heterozygous MEFV exon 2 variantsYushiro Endo, Tomohiro Koga, Masataka Umeda, et al.
Clinical Immunology (Orlando, Fla.)|March 8, 2020
A case of γδ T-cell large granular lymphocytic leukemia due to a chronic active Epstein-Barr virus infection in systemic lupus erythematosusMomoko Okamoto, Kunihiro Ichinose, Shinya Sato, et al.
Pageof 4